Xu Wengui M.D.
Director

Xu Wengui,  doctor of radiology, postdoctoral fellow in internal medicine and oncology of clinical medicine, head of molecular imaging and nuclear medicine department of Tianjin medical university tumor hospital, director of Joint laboratory for molecular imaging of tumors with Institute of high energy physics, Chinese academy of sciences,doctoral advisor of oncology,master's advisor of Imaging and nuclear medicine. He got a bachelor’s degree in 1989 and a master's degree in 1996 from Norman Bethune medical university, and got a doctor's degree of radioactive medicine(radioactive medicine) from Jilin University in 2001, and respectively did postdoctoral research of clinical medicine (internal medicine) in Jilin university in 2004 ang of clinical medicine (oncology)in Tianjin medical university tumor hospital in 2007. He researched and studied molecular imaging of medicine in 2006 as a visiting scholar at the university of Zurich, Switzerland and has obtained substantial Clinical research achievements.

 

Main academic part-time jobs:

Council Member of Chinese Anti-Cancer Association

Chairman of tumor nuclear medicine committee of Chinese Anti-Cancer Association

Member of nuclear medicine branch of Chinese medical doctor association

Council Member of nuclear medicine branchof Chinese nuclear society

Council Member of China society of medical imaging technology

Member of nuclear medicine branch of China society of medical imaging technology

Vice chairman of nuclear medicine branch of Tianjin medical association

Council Member of Tianjin nuclear society

Vice chairman of nuclear medicine branch of Tianjin medical doctor association

Vice chairman of the imaging committee of Tianjin anti-cancer association

Standing committee of lymphoma professional committee of Tianjin anti-cancer association

Standing committee of thyroid professional committee of Tianjin anti-cancer association

 

Main academic achievements:

He mainly engaged in the basic and clinical research of nuclear medicine and tumor molecular imaging, and has strong working foundation and scientific research ability. He presided over one Natural Science Foundation of China, and participated in more than 10  Natural Science Foundation of China and other national research project.He presided over 4 provincial and ministerial-level projects, and participated in a number of scientific research projects at all levels.Among them, more than 10 scientific research achievements have been recognized as provincial achievements,1 third prize as the first executer and 6 third prizes as the main executer of provincial (ministry) scientific and technological progress.He published dozens of academic papers as the first author and corresponding author, including nearly 20 SCI papers. He participated in the preparation of several textbooks and monographs.At present, the main research direction is nuclear medicine and tumor molecular imaging research.

 

Main medical expertise:

He has been engaged in nuclear medicine diagnosis and treatment work for years and has rich clinical experience and a high level of diagnosis and treatment.

1.Radionuclide diagnosis:

(1) PET/CT diagnosis of all kinds of tumors

(2) SPECT/CT diagnosis of various disease

2.Radionuclide treatment:

(1) iodine-131 therapy of differentiated thyroid cancer and its metastases

(2) tumor radioimmunotherapy

(3) radioactive seeds Implant treatment

(4) 89Sr internal irradiation therapy for bone metastasis